| Issue Date | Title | Author(s) | Source | scopus | WOS | Fulltext/Archive link |
|---|---|---|---|---|---|---|
| 2015 | Bevacizumab preconditioning followed by etoposide and cisplatin is highly effective in treating brain metastases of breast cancer progressing from whole-brain radiotherapy | YEN-SHEN LU ; WEI-WU CHEN ; CHING-HUNG LIN ; Yeh D.-C.; Tseng L.-M.; Wu P.-F.; Rau K.-M.; BANG-BIN CHEN ; Chao T.-C.; Huang S.-M.; CHIUN-SHENG HUANG ; TIFFANY TING-FANG SHIH ; ANN-LII CHENG ; Taiwan Breast Cancer Consortium | Clinical Cancer Research | 61 | 53 | |
| 2017 | Combination of palbociclib with enzalutamide shows in vitro activity in RB proficient and androgen receptor positive triple negative breast cancer cells | Liu C.-Y.; Lau K.-Y.; Hsu C.-C.; Chen J.-L.; Lee C.-H.; Huang T.-T.; Chen Y.-T.; Huang C.-T.; PO-HAN LIN ; Tseng L.-M. | PLoS ONE | 39 | 35 | |
| 2013 | Comparison of baseline quality of life scores in patients with bone and brain metastases as assessed using the EORTC QLQ-C30 | Poon M.; Zeng L.; Zhang L.; Tseng L.-M.; Hou M.-F.; Fairchild A.; Vassiliou V.; Jesus-Garcia R.; Alm El-Din M.A.; Kumar A.; Forges F.; WEI-CHU CHIE ; Sahgal A.; Wong E.; Chow E. | Journal of Pain Management | 0 | ||
| 2013 | Comparison of baseline quality of life scores in patients with bone and brain metastases as assessed using the EORTC QLQ-C30 | Poon M.; Zeng L.; Zhang L.; Tseng L.-M.; Hou M.-F.; Fairchild A.; Vassiliou V.; Jesus-Garcia R.; Alm El-Din M.A.; Kumar A.; Forges F.; WEI-CHU CHIE ; Sahgal A.; Wong E.; Chow E. | Advanced Cancer: Managing Symptoms and Quality of Life | 0 | ||
| 2013 | Determinants of quality of life in advanced cancer patients with bone metastases undergoing palliative radiation treatment | Lam K.; Chow E.; Zhang L.; Wong E.; Bedard G.; Fairchild A.; Vassiliou V.; El-Din M.A.; Jesus-Garcia R.; Kumar A.; Forges F.; Tseng L.-M.; Hou M.-F.; WEI-CHU CHIE ; Bottomley A. | Supportive Care in Cancer | 29 | 26 | |
| 2016 | Disrupting VEGF-A paracrine and autocrine loops by targeting SHP-1 suppresses triple negative breast cancer metastasis | Su J.-C.; Mar A.-C.; Wu S.-H.; Tai W.-T.; Chu P.-Y.; Wu C.-Y.; Tseng L.-M.; Lee T.-C.; Chen K.-F.; Liu C.-Y.; HAO-CHIEH CHIU ; Shiau C.-W. | Scientific Reports | 37 | 31 | |
| 2014 | EORTC QLQ-BM22 quality of life evaluation and pain outcome in patients with bone metastases from breast cancer treated with zoledronic acid | Yeh D.-C.; Chen D.-R.; Chao T.-Y.; Chen S.-C.; Wang H.-C.; Rau K.-M.; Feng Y.-H.; Chang Y.-C.; Lee K.-D.; Ou-Yang F.; WEN-HUNG KUO ; KING-JEN CHANG ; Lin Y.-C.; Tseng L.-M.; Hou M.-F. | In Vivo | 6 | 7 | |
| 2013 | Factors influencing health related quality of life in cancer patients with bone metastases | Wong E.; Chow E.; Zhang L.; Bedard G.; Lam K.; Fairchild A.; Vassiliou V.; Alm El-Din M.A.; Jesus-Garcia R.; Kumar A.; Forges F.; Tseng L.-M.; Hou M.-F.; WEI-CHU CHIE ; Bottomley A. | Journal of Palliative Medicine | 16 | 13 | |
| 2014 | Filtering performance of reducing the sampling rate of sound card: Perspectives on different signal-to-noise ratios | Lu B.-Y.; Tseng L.-M.; Hsu L.-Y.; Weng Y.-L.; Tang S.-H.; Hsueh M.-N.; HUEY-DONG WU ; Lai J.-S. | International Conference on Advanced Communication Technology, ICACT | 0 | 0 | |
| 2020 | Globo H-KLH vaccine adagloxad simolenin (OBI-822)/OBI-821 in patients with metastatic breast cancer: phase II randomized, placebo-controlled study | CHIUN-SHENG HUANG ; Yu A.L.; Tseng L.-M.; Chow L.W.C.; Hou M.-F.; Hurvitz S.A.; Schwab R.B.; L Murray J.; Chang H.-K.; Chang H.-T.; Chen S.-C.; Kim S.-B.; Hung J.-T.; Ueng S.-H.; Lee S.-H.; Chen C.-C.; Rugo H.S. | Journal for immunotherapy of cancer | 24 | 22 | |
| 2012 | International field testing of the reliability and validity of the EORTC QLQ-BM22 module to assess health-related quality of life in patients with bone metastases | Chow E.; Nguyen J.; Zhang L.; Tseng L.-M.; Hou M.-F.; Fairchild A.; Vassiliou V.; Jesus-Garcia R.; Alm El-Din M.A.; Kumar A.; Forges F.; WEI-CHU CHIE ; Bottomley A. | Cancer | 63 | 52 | |
| 2012 | An international prospective study establishing minimal clinically important differences in the EORTC QLQ-BM22 and QLQ-C30 in cancer patients with bone metastases | Zeng L.; Chow E.; Zhang L.; Tseng L.-M.; Hou M.-F.; Fairchild A.; Vassiliou V.; Jesus-Garcia R.; El-Din M.A.A.; Kumar A.; Forges F.; WEI-CHU CHIE ; Bedard G.; Bottomley A. | Supportive Care in Cancer | 26 | 17 | |
| 2005 | Laparoscopic appendectomy in pregnancy | Wu J.-M.; Chen K.-H.; Lin H.-F.; Tseng L.-M.; SHENG-HONG TSENG ; Huang S.-H. | Journal of Laparoendoscopic and Advanced Surgical Techniques - Part A | 40 | 30 | |
| 2006 | Laparoscopic Versus Open Appendectomy for Perforated Appendicitis | Lin H.-F.; Wu J.-M.; Tseng L.-M.; Chen K.-H.; Huang S.-H.; I-RUE LAI | Journal of Gastrointestinal Surgery | 63 | 55 | |
| 2021 | Molecular subtyping of breast cancer intrinsic taxonomy with oligonucleotide microarray and NanoString nCounter | Chen Y.-J.; Huang C.-S.; Phan N.-N.; TZU-PIN LU ; Liu C.-Y.; Huang C.-J.; Chiu J.-H.; Tseng L.-M.; Huang C.-C. | Bioscience Reports | 2 | 2 | |
| 2022 | Neoadjuvant afatinib with paclitaxel for triple-negative breast cancer and the molecular characteristics in responders and non-responders | PO-HAN LIN ; Tseng L.-M.; Lee Y.-H.; Chen S.-T.; Yeh D.-C.; Dai M.-S.; Liu L.-C.; MING-YANG WANG ; Lo C.; Chang S.; Tan K.T.; Chen S.-J.; SUNG-HSIN KUO ; Huang C.-S. | Journal of the Formosan Medical Association | 1 | 1 | |
| 2021 | Pertuzumab and trastuzumab as adjuvant treatment for HER2-positive early breast cancer: outcomes in Chinese patients in the APHINITY study | Shao Z.; Tseng L.-M.; CHIUN-SHENG HUANG ; Pang D.; Yang Y.; Li W.; Liao N.; Geng C.; Zhang Q.; Xu B.; Liu D.; Kwong A.; et al (continued in the appendix) | Japanese journal of clinical oncology | 2 | 1 | |
| 2021 | A phase ib study of alpelisib or buparlisib combined with tamoxifen plus goserelin in premenopausal women with HR-positive HER2-negative advanced breast cancer | YEN-SHEN LU ; Lee K.S.; Chao T.-Y.; Tseng L.-M.; Chitapanarux I.; Chen S.-C.; Liu C.-T.; Sohn J.; Kim J.H.; Chang Y.-C.; Yang Y.; Shotelersuk K.; Jung K.H.; Valenti R.; Slader C.; Gao M.; Park Y.H. | Clinical Cancer Research | 18 | 15 | |
| 2011 | Phase II study of docetaxel, capecitabine, and cisplatin as neoadjuvant chemotherapy for locally advanced breast cancer | YEN-SHEN LU ; Chen D.-R.; Tseng L.-M.; Yeh D.-C.; Chen S.-T.; Hsieh C.-M.; Wang H.-C.; Yeh H.-T.; SUNG-HSIN KUO ; CHIUN-SHENG HUANG | Cancer Chemotherapy and Pharmacology | 10 | 8 | |
| 2014 | Predictive factors of overall quality of life in advanced cancer patients using EORTC QLQ-C30 | Cramarossa G.; Zeng L.; Zhang L.; Tseng L.-M.; Hou M.-F.; Fairchild A.; Vassiliou V.; Jesus-Garcia R.; Alm El-Din M.A.; Kumar A.; Forges F.; WEI-CHU CHIE ; Sahgal A.; Lam H.; Pulenzas N.; Chow E. | Expert Review of Pharmacoeconomics and Outcomes Research | 6 | 5 |
